skip to main content
Idioma:
Você quis dizer: sola flavio?
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Tumor clonality and resistance mechanisms in EGFR mutation-positive non-small-cell lung cancer: implications for therapeutic sequencing
Tumor clonality and resistance mechanisms in EGFR mutation-positive non-small-cell lung cancer: implications for therapeutic sequencing
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tumor clonality and resistance mechanisms in EGFR mutation-positive non-small-cell lung cancer: implications for therapeutic sequencing

Kohsaka, Shinji ; Petronczki, Mark ; Solca, Flavio ; Maemondo, Makoto

Future oncology (London, England), 2019-02, Vol.15 (6), p.637-652 [Periódico revisado por pares]

England: Future Medicine Ltd

Texto completo disponível

Citações Citado por
2
Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker
Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker
Material Type:
Artigo 		Adicionar ao Meu Espaço

Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker

Solca, Flavio ; Dahl, Goeran ; Zoephel, Andreas ; Bader, Gerd ; Sanderson, Michael ; Klein, Christian ; Kraemer, Oliver ; Himmelsbach, Frank ; Haaksma, Eric ; Adolf, Guenther R

The Journal of pharmacology and experimental therapeutics, 2012-11, Vol.343 (2), p.342-350 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer
A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer

Modjtahedi, Helmout ; Cho, Byoung Chul ; Michel, Martin C. ; Solca, Flavio

Naunyn-Schmiedeberg's archives of pharmacology, 2014-06, Vol.387 (6), p.505-521 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
4
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report
Material Type:
Artigo 		Adicionar ao Meu Espaço

Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report

Yang, James Chih-Hsin ; Schuler, Martin ; Popat, Sanjay ; Miura, Satoru ; Park, Keunchil ; Passaro, Antonio ; De Marinis, Filippo ; Solca, Flavio ; Märten, Angela ; Kim, Edward S

Frontiers in oncology, 2022-04, Vol.12, p.834704-834704 [Periódico revisado por pares]

Switzerland: Frontiers Media S.A

Texto completo disponível

Citações Citado por
5
Correction to: Afatinib is active in osteosarcoma cell lines
Correction to: Afatinib is active in osteosarcoma cell lines
Material Type:
Artigo 		Adicionar ao Meu Espaço

Correction to: Afatinib is active in osteosarcoma cell lines

Cruz-Ramos, Marlid ; Zamudio-Cuevas, Yessica ; Medina-Luna, Daniel ; Martínez-Flores, Karina ; Martínez-Nava, Gabriela ; Fernández-Torres, Javier ; López-Reyes, Alberto ; Solca, Flavio

Journal of cancer research and clinical oncology, 2020-10, Vol.146 (10), p.2719-2719 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
6
Afatinib is active in osteosarcoma in osteosarcoma cell lines
Afatinib is active in osteosarcoma in osteosarcoma cell lines
Material Type:
Artigo 		Adicionar ao Meu Espaço

Afatinib is active in osteosarcoma in osteosarcoma cell lines

Cruz-Ramos, Marlid ; Zamudio-Cuevas, Yessica ; Medina-Luna, Daniel ; Martínez-Flores, Karina ; Martínez-Nava, Gabriela ; Fernández-Torres, Javier ; López-Reyes, Alberto ; Solca, Flavio

Journal of cancer research and clinical oncology, 2020-07, Vol.146 (7), p.1693-1700 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
7
Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer
Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer

Canonici, Alexandra ; Browne, Alacoque L. ; Ibrahim, Mohamed F. K. ; Fanning, Kevin P. ; Roche, Sandra ; Conlon, Neil T. ; O’Neill, Fiona ; Meiller, Justine ; Cremona, Mattia ; Morgan, Clare ; Hennessy, Bryan T. ; Eustace, Alex J. ; Solca, Flavio ; O’Donovan, Norma ; Crown, John

Therapeutic advances in medical oncology, 2020-01, Vol.12, p.1758835919897546-1758835919897546 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

Citações Citado por
8
Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation
Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation

Zöchbauer-Müller, Sabine ; Kaserer, Bettina ; Prosch, Helmut ; Cseh, Agnieszka ; Solca, Flavio ; Bauer, Markus Johann ; Müllauer, Leonhard

Frontiers in oncology, 2021-01, Vol.10, p.593852 [Periódico revisado por pares]

Switzerland: Frontiers Research Foundation

Texto completo disponível

Citações Citado por
9
Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cells
Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cells

Kim, Sun Mi ; Kim, Ji Su ; Kim, Joo-Hang ; Yun, Chae-Ok ; Kim, Eun Mi ; Kim, Hyun Ki ; Solca, Flavio ; Choi, Soo-Young ; Cho, Byoung Chul

Cancer letters, 2010-10, Vol.296 (2), p.150-159 [Periódico revisado por pares]

Ireland: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
10
Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo
Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo
Material Type:
Artigo 		Adicionar ao Meu Espaço

Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo

Young, Natalie R. ; Soneru, Christian ; Liu, Jing ; Grushko, Tatyana A. ; Hardeman, Ashley ; Olopade, Olufunmilayo I. ; Baum, Anke ; Solca, Flavio ; Cohen, Ezra E. W.

Targeted oncology, 2015-12, Vol.10 (4), p.501-508 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (74)
  2. Revistas revisadas por pares (76)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (82)
  2. Reports  (2)
  3. Conjunto de Dados  (1)
  4. Book Chapters  (1)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1996  (10)
  2. 1996Até2006  (6)
  3. 2007Até2012  (21)
  4. 2013Até2018  (24)
  5. Após 2018  (28)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (85)
  2. Japonês  (7)
  3. Turco  (1)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.